<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="caused by SARS-CoV-2 is called COVID-19. The symptoms of the" exact="SARS-CoV-2 infection" post="range from asymptomatic to mild to severe to death.1"/>
 <result pre="generally less pathogenic than SARS-CoV, much less pathogenic than the" exact="Middle East respiratory syndrome" post="MERS-CoV, but more pathogenic than practically harmless HCoV-OC43, HCoV-HKU1,"/>
 <result pre="500 million 40â€&quot;100 million SARS (SARS-CoV)2002â€&quot;2003 N/A 30% 8,000 800" exact="Covid-19" post="(SARS-CoV-2)Since November 2019 &amp;gt;2% â‰¤3% &amp;gt;4,500,000 &amp;gt;300,000 Swine flu"/>
 <result pre="attachment step that primarily determines which host is susceptible to" exact="SARS-CoV infection." post="The SARS-CoV-2 entry through receptor bindingÂ was elucidated independently"/>
 <result pre="of novel mutations at the 501 position in SARS-CoV-2-infected and" exact="Covid-19" post="patients have to be closely monitored.34 Mutations in the"/>
 <result pre="in China.39 FigureÂ 7 Structures of Four Promising Drugs for" exact="Covid-19" post="Treatment and an Aristeromycin Derivative Favipiravir 24 is now"/>
 <result pre="Favipiravir 24 is now the first approved drug to treat" exact="Covid-19" post="The broad-spectrum antiviral drug remdesivir together with chloroquine effectively"/>
 <result pre="recently emerged novel CoV (SARS-CoV-2) inÂ vitro.40,41 Remdesivir (25) reduced" exact="SARS-CoV-2 infection" post="of monkey kidney cells with an EC50 of 0.77Â"/>
 <result pre="to inhibit multiple RNA viruses on a cellular level, including" exact="Ebola" post="and SARS. The presumed mode of action of the"/>
 <result pre="It is an adenosine analog and is currently developed for" exact="Ebola" post="virus disease and Marburg virus disease. It also shows"/>
 <result pre="analog and is currently developed for Ebola virus disease and" exact="Marburg virus disease." post="It also shows broad-spectrum antiviral activity against RNA virus"/>
 <result pre="COVID-19Nat. Nanotechnol.15202024724932203437 42WarrenT.K.JordanR.LoM.K.RayA.S.MackmanR.L.SolovevaV.SiegelD.PerronM.BannisterR.HuiH.C.Therapeutic efficacy of the small molecule GS-5734 against" exact="Ebola" post="virus in rhesus monkeysNature531201638138526934220 43WestoverJ.B.MathisA.TaylorR.WanderseeL.BaileyK.W.SefingE.J.HickersonB.T.JungK.H.SheridanW.P.GowenB.B.Galidesivir limits Rift Valley fever"/>
 <result pre="molecule GS-5734 against Ebola virus in rhesus monkeysNature531201638138526934220 43WestoverJ.B.MathisA.TaylorR.WanderseeL.BaileyK.W.SefingE.J.HickersonB.T.JungK.H.SheridanW.P.GowenB.B.Galidesivir limits" exact="Rift Valley fever" post="virus infection and disease in Syrian golden hamstersAntiviral Res.1562018384529864447"/>
</results>
